GPCR
Structure Therapeutics Inc. American Depositary Shares
NASDAQ: GPCR · HEALTHCARE · BIOTECHNOLOGY
$41.37
-5.04% today
Updated 2026-04-29
Market cap
$2.94B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.40
Dividend yield
—
52W range
$16 – $95
Volume
1.0M
Structure Therapeutics Inc. American Depositary Shares (GPCR) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — |
| Cost of revenue | $20034.00 | $266353.00 | $623258.00 | $949174.00 | $2.60M | $3.90M |
| Gross profit | $-20034.00 | $-266353.00 | $-623258.00 | $-949174.00 | $-2.60M | $-3.90M |
| Gross margin | — | — | — | — | — | — |
| R&D | $12364.00 | $29.11M | $36.19M | $70.10M | $108.81M | $225.25M |
| SG&A | $3542.00 | $8.59M | $16.37M | $32.67M | $49.41M | $61.55M |
| Operating income | $-15906.00 | $-37.70M | $-52.56M | $-102.78M | $-158.23M | $-287.57M |
| Operating margin | — | — | — | — | — | — |
| EBITDA | $-15906.00 | $-37.62M | $-52.28M | $-102.48M | $-157.24M | $-136.79M |
| EBITDA margin | — | — | — | — | — | — |
| EBIT | $-15906.00 | $-37.70M | $-52.56M | $-102.78M | $-158.23M | $-140.69M |
| Interest expense | $5.00 | $122161.00 | $1.53M | $13.39M | — | — |
| Income tax | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-15876.00 | $-40.01M | $-51.32M | $-89.62M | $-122.53M | $-141.20M |
| Net income growth (YoY) | — | -251903.0% | -28.3% | -74.6% | -36.7% | -15.2% |
| Profit margin | — | — | — | — | — | — |